Richard Pencek

3.4k total citations
60 papers, 1.8k citations indexed

About

Richard Pencek is a scholar working on Hepatology, Surgery and Molecular Biology. According to data from OpenAlex, Richard Pencek has authored 60 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 20 papers in Surgery and 20 papers in Molecular Biology. Recurrent topics in Richard Pencek's work include Liver Diseases and Immunity (23 papers), Metabolism, Diabetes, and Cancer (18 papers) and Liver Disease Diagnosis and Treatment (17 papers). Richard Pencek is often cited by papers focused on Liver Diseases and Immunity (23 papers), Metabolism, Diabetes, and Cancer (18 papers) and Liver Disease Diagnosis and Treatment (17 papers). Richard Pencek collaborates with scholars based in United States, Italy and Netherlands. Richard Pencek's co-authors include David H. Wasserman, Deanna P. Bracy, Patrick T. Fueger, Leigh MacConell, Д. А. Шапиро, Jane Shearer, Gideon M. Hirschfield, Carlo M. Malabanan, Christopher L. Bowlus and D. Borden Lacy and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Hepatology.

In The Last Decade

Richard Pencek

60 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard Pencek United States	24	645	570	527	485	478	60	1.8k
Kengo Tomita Japan	23	327 0.5×	425 0.7×	691 1.3×	264 0.5×	230 0.5×	57	1.5k
Simon W. Beaven United States	17	368 0.6×	518 0.9×	444 0.8×	152 0.3×	241 0.5×	27	1.5k
Mingjiang Xu United States	22	175 0.3×	668 1.2×	959 1.8×	299 0.6×	245 0.5×	33	1.9k
Cindy Kunne Netherlands	25	719 1.1×	513 0.9×	339 0.6×	141 0.3×	122 0.3×	35	1.7k
Nancy Solı́s Chile	22	270 0.4×	273 0.5×	640 1.2×	262 0.5×	325 0.7×	53	1.3k
Z. Gordon Jiang United States	23	335 0.5×	336 0.6×	705 1.3×	420 0.9×	321 0.7×	88	1.6k
Marica Cariello Italy	24	367 0.6×	632 1.1×	332 0.6×	131 0.3×	133 0.3×	54	1.6k
Zbigniew Konopski Norway	16	224 0.3×	308 0.5×	1.1k 2.1×	433 0.9×	447 0.9×	28	1.6k
Niels Kloosterhuis Netherlands	19	268 0.4×	713 1.3×	535 1.0×	77 0.2×	174 0.4×	46	1.7k
Arian Afendy United States	19	475 0.7×	564 1.0×	2.7k 5.2×	1.2k 2.4×	1.3k 2.7×	33	3.3k

Countries citing papers authored by Richard Pencek

Since Specialization

Citations

This map shows the geographic impact of Richard Pencek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Pencek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Pencek more than expected).

Fields of papers citing papers by Richard Pencek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Pencek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Pencek. The network helps show where Richard Pencek may publish in the future.

Co-authorship network of co-authors of Richard Pencek

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Pencek. A scholar is included among the top collaborators of Richard Pencek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Pencek. Richard Pencek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hirschfield, Gideon M., Palak Trivedi, Cynthia Levy, et al.. (2023). INTEGRIS-PSC phase 2a study: evaluating the safety, tolerability, and pharmacokinetics of bexotegrast (PLN-74809) in participants with primary sclerosing cholangitis. Journal of Hepatology. 78. S356–S356. 1 indexed citations

Trauner, Michael, Frederik Nevens, Mitchell L. Shiffman, et al.. (2019). Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study. The Lancet. Gastroenterology & hepatology. 4(6). 445–453. 124 indexed citations

Hirschfield, Gideon M., Annarosa Floreani, Richard Pencek, et al.. (2017). PTU-097 Long-term effect of obeticholic acid on transient elastography and ast to platelet ratio index in patients with pbc. Gut. 66. A98.3–A99. 1 indexed citations

Pencek, Richard, Tracy J. Mayne, Marco Carbone, et al.. (2015). Parallel 23: Fatty Liver Disease: Clinical and Therapeutic I. Hepatology. 62(S1). 288A–291A. 2 indexed citations

Parés, Albert, Richard Pencek, Yonne Peters, et al.. (2015). P1155 : FXR Agonism with obeticholic acid may attenuate bone mineral density decrease in subjects with primary biliary cirrhosis. Journal of Hepatology. 62. S786–S786. 3 indexed citations

Blonde, Lawrence, Richard Pencek, & Leigh MacConell. (2015). Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes. Cardiovascular Diabetology. 14(1). 12–12. 61 indexed citations

Buse, John B., et al.. (2014). Addition of exenatide BID to insulin glargine: a post-hoc analysis of the effect on glycemia and weight across a range of insulin titration. Current Medical Research and Opinion. 30(7). 1209–1218. 8 indexed citations

Ridge, Terry, Leigh MacConell, Richard Pencek, et al.. (2012). Comparison of safety and tolerability with continuous (exenatide once weekly) or intermittent (exenatide twice daily) GLP ‐1 receptor agonism in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 14(12). 1097–1103. 28 indexed citations

Pencek, Richard, et al.. (2012). Exenatide Twice Daily: Analysis of Effectiveness and Safety Data Stratified by Age, Sex, Race, Duration of Diabetes, and Body Mass Index. Postgraduate Medicine. 124(4). 21–32. 44 indexed citations

10.

Pencek, Richard, et al.. (2012). Exenatide once weekly for the treatment of type 2 diabetes: effectiveness and tolerability in patient subpopulations. International Journal of Clinical Practice. 66(11). 1021–1032. 43 indexed citations

11.

Pencek, Richard, Steven C. Brunell, Yan Li, Byron J. Hoogwerf, & James Malone. (2012). Use of Concomitant Glucose-Lowering Therapies and Associated Treatment Results Observed in Clinical Trials of Twice-Daily Exenatide. Endocrine Practice. 18(2). 227–237. 12 indexed citations

12.

Pencek, Richard, Steven C. Brunell, Yan Li, Byron J. Hoogwerf, & James Malone. (2012). Exenatide Once Weekly for the Treatment of Type 2 Diabetes Mellitus: Clinical Results in Subgroups of Patients Using Different Concomitant Medications. Postgraduate Medicine. 124(4). 33–40. 13 indexed citations

13.

Taylor, Kristin, et al.. (2011). Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years. BMC Endocrine Disorders. 11(1). 9–9. 56 indexed citations

14.

Chase, H. Peter, Karen Lutz, Richard Pencek, Bei Zhang, & Lisa A. Porter. (2009). Pramlintide Lowered Glucose Excursions and Was Well-Tolerated in Adolescents with Type 1 Diabetes: Results from a Randomized, Single-Blind, Placebo-Controlled, Crossover Study. The Journal of Pediatrics. 155(3). 369–373. 26 indexed citations

15.

Pencek, Richard, Alessandra Bertoldo, Julie C. Price, et al.. (2006). Dose-responsive insulin regulation of glucose transport in human skeletal muscle. American Journal of Physiology-Endocrinology and Metabolism. 290(6). E1124–E1130. 11 indexed citations

16.

Pencek, Richard, Patrick T. Fueger, Raul C. Camacho, & David H. Wasserman. (2005). Mobilization of Glucose From the Liver During Exercise and Replenishment Afterward. Canadian Journal of Applied Physiology. 30(3). 292–303. 7 indexed citations

17.

Fueger, Patrick T., Jane Shearer, Deanna P. Bracy, et al.. (2004). Control of muscle glucose uptake: test of the rate‐limiting step paradigm in conscious, unrestrained mice. The Journal of Physiology. 562(3). 925–935. 48 indexed citations

18.

Fueger, Patrick T., Deanna P. Bracy, Carlo M. Malabanan, Richard Pencek, & David H. Wasserman. (2004). Distributed control of glucose uptake by working muscles of conscious mice: roles of transport and phosphorylation. American Journal of Physiology-Endocrinology and Metabolism. 286(1). E77–E84. 50 indexed citations

19.

Pencek, Richard, Freyja D. James, D. Borden Lacy, et al.. (2003). Interaction of Insulin and Prior Exercise in Control of Hepatic Metabolism of a Glucose Load. Diabetes. 52(8). 1897–1903. 23 indexed citations

20.

Pencek, Richard, D. Borden Lacy, Freyja D. James, et al.. (2002). Transporter-Mediated Absorption Is the Primary Route of Entry and Is Required for Passive Absorption of Intestinal Glucose into the Blood of Conscious Dogs. Journal of Nutrition. 132(7). 1929–1934. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact